Coca-Cola FEMSA SAB de CV:戦略・SWOT・企業財務分析

◆英語タイトル:Coca-Cola FEMSA SAB de CV - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA8015236
◆発行会社(調査会社):MarketLine
◆発行日:2017年9月30日
◆ページ数:53
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:メキシコ
◆産業分野:消費財
◆販売価格オプション(消費税別)
Single UserUSD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Coca-Cola FEMSA SAB de CV – Strategy, SWOT and Corporate Finance Report
Summary

Coca-Cola FEMSA SAB de CV – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Coca-Cola FEMSA, S.A.B. de C.V. (Coca-Cola FEMSA or ‘the company’) and its subsidiaries are engaged in the production, distribution and marketing of certain Coca-Cola trademark beverages licensed from Fomento Economico Mexicano, S.A.B. de C.V. (FEMSA). The company primarily operates in Mexico, Central America (Guatemala, Nicaragua, Costa Rica and Panama), Colombia, Venezuela, Brazil and Argentina. It is headquartered in Mexico City, Mexico and employed 83,712 people as of December 31, 2015.

Scope

- Detailed information on Coca-Cola FEMSA SAB de CV required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Coca-Cola FEMSA SAB de CV in the form of a SWOT analysis
- An in-depth view of the business model of Coca-Cola FEMSA SAB de CV including a breakdown and examination of key business segments
- Intelligence on Coca-Cola FEMSA SAB de CV’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Coca-Cola FEMSA SAB de CV, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Coca-Cola FEMSA SAB de CV and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Coca-Cola FEMSA SAB de CV as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Coca-Cola FEMSA SAB de CV’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Coca-Cola FEMSA SAB de CV: Company Overview
Coca-Cola FEMSA SAB de CV: Overview and Key Facts
Coca-Cola FEMSA SAB de CV: Overview
Coca-Cola FEMSA SAB de CV: Key Facts
Coca-Cola FEMSA SAB de CV: Key Employees
Coca-Cola FEMSA SAB de CV: Key Employee Biographies
Coca-Cola FEMSA SAB de CV: Major Products and Services
Coca-Cola FEMSA SAB de CV: Company History
Coca-Cola FEMSA SAB de CV: Management Statement
Coca-Cola FEMSA SAB de CV: Locations and Subsidiaries
Coca-Cola FEMSA SAB de CV: Key Competitors
Coca-Cola FEMSA SAB de CV: Company Analysis
Coca-Cola FEMSA SAB de CV: Business Description
Coca-Cola FEMSA SAB de CV: SWOT Analysis
Coca-Cola FEMSA SAB de CV: SWOT Overview
Coca-Cola FEMSA SAB de CV: Strengths
Coca-Cola FEMSA SAB de CV: Weaknesses
Coca-Cola FEMSA SAB de CV: Opportunities
Coca-Cola FEMSA SAB de CV: Threats
Coca-Cola FEMSA SAB de CV: Corporate Financial Deals Activity
Coca-Cola FEMSA SAB de CV: Financial Deals Overview
Coca-Cola FEMSA SAB de CV: Targets and Partners
Coca-Cola FEMSA SAB de CV: Top Deals 2013 – 2017YTD*
Coca-Cola FEMSA SAB de CV: Advisors
Coca-Cola FEMSA SAB de CV: Top Legal Advisors
Coca-Cola FEMSA SAB de CV: Top Financial Advisors
Coca-Cola FEMSA SAB de CV: Mergers and Acquisitions
Coca-Cola FEMSA SAB de CV: Capital Raising
Coca-Cola FEMSA SAB de CV: Recent Developments
Coca-Cola FEMSA SAB de CV: News and Events Summary
Coca-Cola FEMSA SAB de CV: Business Expansion
Coca-Cola FEMSA SAB de CV: Contracts
Coca-Cola FEMSA SAB de CV: Corporate Governance
Coca-Cola FEMSA SAB de CV: Financial Deals
Coca-Cola FEMSA SAB de CV: Financial Performance
Coca-Cola FEMSA SAB de CV: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Coca-Cola FEMSA SAB de CV: Key Facts
Table 2: Coca-Cola FEMSA SAB de CV: Key Employees
Table 3: Coca-Cola FEMSA SAB de CV: Locations and Subsidiaries
Table 4: Coca-Cola FEMSA SAB de CV: Key Competitors
Table 5: Coca-Cola FEMSA SAB de CV: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 6: Coca-Cola FEMSA SAB de CV: M&A Average Deal Size - Value (US$m)
Table 7: Coca-Cola FEMSA SAB de CV: Targets and Partners
Table 8: Coca-Cola FEMSA SAB de CV: Top Deals 2013 - 2017YTD*
Table 9: Coca-Cola FEMSA SAB de CV: Legal Advisor Ranking by Value (US$m)
Table 10: Coca-Cola FEMSA SAB de CV: Financial Advisor Ranking by Value (US$m)
Table 11: Coca-Cola FEMSA SAB de CV: M&A Volume and Value Trend (2013 - YTD*2017)
Table 12: Coca-Cola FEMSA SAB de CV: M&A Activity by Geography (2013 - YTD*2017)
Table 13: Coca-Cola FEMSA SAB de CV: Capital Raising Volume and Value Trend (2013 - YTD*2017)
Table 14: Coca-Cola FEMSA SAB de CV: Capital Raising by Deal Type (2013 - YTD*2017)
Table 15: Coca-Cola FEMSA SAB de CV: News and Events Summary
Table 16: Coca-Cola FEMSA SAB de CV: Business Expansion
Table 17: Coca-Cola FEMSA SAB de CV: Contracts
Table 18: Coca-Cola FEMSA SAB de CV: Corporate Governance
Table 19: Coca-Cola FEMSA SAB de CV: Financial Deals
Table 20: Coca-Cola FEMSA SAB de CV: Financial Performance
Table 21: Coca-Cola FEMSA SAB de CV: Strategy and Operations

★海外企業調査レポート[Coca-Cola FEMSA SAB de CV:戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AB Science SA (AB):企業の財務・戦略的SWOT分析
    Summary AB Science SA (ABS) is a pharmaceutical company focused on discovery, development, and commercialization of protein kinase inhibitors. The company's lead compound Masitinib, is a orally administered tyrosine kinase inhibitor targeting mast cells and selected kinases, including c-Kit, PDGFR, …
  • Yanlord Land Group Ltd:戦略・SWOT・企業財務分析
    Yanlord Land Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Yanlord Land Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Encompass Health Corp (EHC):企業の財務・戦略的SWOT分析
    Encompass Health Corp (EHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Cabot Oil & Gas Corporation (COG)-石油・ガス分野:企業M&A・提携分析
    Summary Cabot Oil & Gas Corporation (Cabot) is an independent oil and gas company, which develops, and explores for oil and gas properties primarily in the continental US. It focuses on developing natural gas resources in the Marcellus shale in northeast Pennsylvania and oil development in the Eagle …
  • GlycoMimetics Inc (GLYC):企業の財務・戦略的SWOT分析
    GlycoMimetics Inc (GLYC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Glorious Sun Enterprises Limited (393):企業の財務・戦略的SWOT分析
    Glorious Sun Enterprises Limited (393) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Trusted Media Brands, Inc.:企業の戦略的SWOT分析
    Trusted Media Brands, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Molnlycke Health Care AB-医療機器分野:企業M&A・提携分析
    Summary Molnlycke Health Care AB (Molnlycke) a subsidiary of Investor AB, is a medical device company. The company carries out the manufacturing and marketing of single-use surgical and wound care products. The company offers a range of surgical and wound care products; infection prevention solution …
  • Asian Development Bank:企業のM&A・事業提携・投資動向
    Asian Development Bank - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Asian Development Bank Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • AB Orlen Lietuva:企業の戦略的SWOT分析
    AB Orlen Lietuva - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • H-E-B Grocery Company L.P.:企業の戦略・SWOT・財務情報
    H-E-B Grocery Company L.P. - Strategy, SWOT and Corporate Finance Report Summary H-E-B Grocery Company L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • PetroChina Co Ltd (857):企業の財務・戦略的SWOT分析
    PetroChina Co Ltd (857) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • CNP Assurances SA:企業のM&A・事業提携・投資動向
    CNP Assurances SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CNP Assurances SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Bauer AG (B5A):企業の財務・戦略的SWOT分析
    Bauer AG (B5A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • PT Pembangkitan Jawa-Bali-エネルギー分野:企業M&A・提携分析
    Summary PT Pembangkitan Jawa-Bali (PJB), a subsidiary of PT PLN (Persero), generates and supplies electricity. It is responsible to meet the electricity requirements of the Java-Madura-Bali (JAMALI) electric system. The company generates electricity from energy sources such as oil, natural gas, coal …
  • Mayo Clinic-医療機器分野:企業M&A・提携分析
    Summary Mayo Clinic (Mayo) is a not-for-profit medical practice and medical research organization. It provides comprehensive medical facilities and programs related to patient care services, research and medical education. It offers specialized medical care with medical departments and centers in mo …
  • 21st Century Oncology Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary 21st Century Oncology Inc. (21st Century Oncology), a subsidiary of 21st Century Oncology Holdings, Inc., is a provider of integrated cancer care services (ICC). It operates through an integrated network of cancer treatment centers and affiliated physicians with specialization in radiation o …
  • Lixte Biotechnology Holdings Inc (LIXT):製薬・医療:M&Aディール及び事業提携情報
    Summary Lixte Biotechnology Holdings Inc (Lixte) is a clinical stage pharmaceutical company, which focuses on the discovery of novel drugs for the treatment of cancer and non-malignant diseases. It develops comprises two classes of drugs, namely, protein phosphatase inhibitors (PTase-i) designated a …
  • BioTime Inc (BTX)-医療機器分野:企業M&A・提携分析
    Summary BioTime Inc (BioTime) is a biotechnology company which focuses on regenerative medicine and plasma volume expanders. The company’s Hextend is a blood plasma volume expander used for the treatment of hypovolemia in surgery, emergency trauma treatment, and other applications. It is also develo …
  • Bank of Nanjing Co., Ltd.:戦略・SWOT・企業財務分析
    Bank of Nanjing Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Bank of Nanjing Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆